Metabolic Syndrome and Cardiovascular Risk Factors in a National Sample of Adolescent Population in the Middle East and North Africa: The CASPIAN III Study - Wikidata - awgldk - TriplyDB

Metabolic Syndrome and Cardiovascular Risk Factors in a National Sample of Adolescent Population in the Middle East and North Africa: The CASPIAN III Study

Metabolic Syndrome and Cardiovascular Risk Factors in a National Sample of Adolescent Population in the Middle East and North Africa: The CASPIAN III Study

http://www.wikidata.org/entity/Q36634531

about

A Systematic Review of Studies on Blood Pressure in Iranian Pediatric Population: First Report From the Middle East and North Africa Prevalence of dyslipidemia in Iranian children and adolescents: A systematic review A Systematic Review on the Prevalence of Overweight and Obesity, in Iranian Children and Adolescents The Prevalence and Awareness of Cardiovascular Diseases Risk Factors among the Lebanese Population: A Prospective Study Comparing Urban to Rural Populations.Prevalence of cardio-metabolic risk factors in a nationally representative sample of Iranian adolescents: The CASPIAN-III Study Physical inactivity and associated factors in Iranian children and adolescents: the Weight Disorders Survey of the CASPIAN-IV study.Prevalence of obesity and overweight in adults and children in Iran; a systematic review.An overview on the successes, challenges and future perspective of a national school-based surveillance program: the CASPIAN study Is the association of continuous metabolic syndrome risk score with body mass index independent of physical activity? The CASPIAN-III study.Joint Association of Screen Time and Physical Activity with Cardiometabolic Risk Factors in a National Sample of Iranian Adolescents: The CASPIANIII Study.Tooth brushing and cardiometabolic risk factors in adolescents: Is there an association? The CASPIAN-III study Multidisciplinary approach to the treatment of obese adolescents: effects on cardiovascular risk factors, inflammatory profile, and neuroendocrine regulation of energy balance.Association of ghrelin with cardiometabolic risk factors in Iranian adolescents: the CASPIAN-III study.Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study.A systematic review on the prevalence of metabolic syndrome in Iranian children and adolescents.Association between psychosocial distress with cardio metabolic risk factors and liver enzymes in a nationally-representative sample of Iranian children and adolescents: the CASPIAN-III study.Prevalence of Prehypertension and Hypertension in a Nationally Representative Sample of Iranian Children and Adolescents: The CASPIAN-IV Study Waist-to-height ratio, body mass index and waist circumference for screening paediatric cardio-metabolic risk factors: a meta-analysis.Association of serum lead and mercury level with cardiometabolic risk factors and liver enzymes in a nationally representative sample of adolescents: the CASPIAN-III study.Association between body mass index and perceived weight status with self-rated health and life satisfaction in Iranian children and adolescents: the CASPIAN-III study.Sex difference in the prevalence of metabolic syndrome and cardiovascular-related risk factors in urban adults from 33 communities of China: The CHPSNE study.Are active and passive smoking associated with cardiometabolic risk factors in adolescents? The CASPIAN-III Study.Analysis of Factors Affecting the Body Mass Index in a National Sample of Iranian Children and Adolescents: Bootstrapping Regression.Association of serum complement C3 with metabolic syndrome components in normal weight obese women.Associations between metabolic syndrome components and markers of inflammation in Welsh school children.Association of Perceived Weight Status versus Body Mass Index on Adherence to Weight-modifying plan Among Iranian Children and Adolescents: The CASPIAN-IV Study.Are active and passive smoking associated with cardiometabolic risk factors in adolescents? The CASPIAN-III Study.Instability of different adolescent metabolic syndrome definitions tracked into early adulthood metabolic syndrome: Tehran Lipid and Glucose Study (TLGS).Attitudes of Jordanian Adolescent Students Toward Overweight and Obesity.

P2860

Q26745726-ECF2FBC8-8F52-4B28-AF28-36305424B61A Q26781062-ABD2166E-C7AC-4CDF-9FB6-A9895BCC1BE4 Q28075841-F2E6E212-724B-4165-85A7-B7EAB7F7BD76 Q33561470-DEB8F32B-7A1C-481C-A1C6-AB548C4885FE Q33593669-A9909766-98E7-43F4-9D6A-6EC0D6F63922 Q33593686-3E34F506-3D4E-499C-A9B9-877EA4BA965A Q34992407-77047778-7BBB-4E64-8407-7402316D4AA7 Q34996331-B6E31A13-C63A-4143-A740-2F04DC33FE39 Q35912264-6BE19A56-019D-4FC9-9FCB-C0439AEC8DAE Q36014369-E24A7348-55FA-4CD5-9AC2-3A57678D901D Q36789483-08D9E588-3718-45F1-AFB2-E82C095C17A9 Q37304427-BC0F57B1-53B1-4A87-862B-00B2FB225D99 Q37359199-1D97FF31-D955-448A-B9D6-B9BBC28FE9CB Q37387548-B372B99B-A135-44BA-83EE-D8A2F2E52A8F Q37593773-784E15BF-4123-4C65-81B7-67C318706F4C Q37684499-5ACE7C4B-A7E6-4485-A66F-5FF7F3B2B5F5 Q37709356-68F6E0FB-5B4D-42B7-8CD6-3DA822705F98 Q38907086-85E75A0C-D63B-4E9C-977D-FC478F2AAA59 Q39160507-EE7CF685-4715-4E92-B25E-49FB061E8824 Q40208526-C6D86ADD-4E6F-429D-A832-D8848F2C0B22 Q40256300-87CBBC78-B7E9-4A9A-8CE7-CB8B8273D65D Q41685795-40AB3073-DB6A-45A3-B976-FBDEB432FC1B Q47095318-42C7E00E-6479-4726-B484-B54F3C635FEF Q47153561-E8CDD0F0-8249-4CF5-BFF4-70F11641992F Q47186191-8C8343C8-CCE9-4324-9D83-E1F47A6AED32 Q47352024-A2106363-3B55-4018-88CC-D4736EF9F133 Q47826222-AF35D456-6DEA-4369-8C88-B4CBC80E1690 Q48874838-09FC32C2-15A4-4F98-94E4-8185BD2BA793 Q49874518-D0C5E3BC-A4E6-48A1-A935-E9DC14594C21

P2860

Metabolic Syndrome and Cardiovascular Risk Factors in a National Sample of Adolescent Population in the Middle East and North Africa: The CASPIAN III Study

http://www.wikidata.org/entity/Q36634531

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Metabolic Syndrome and Cardiov ...... Africa: The CASPIAN III Study

@ast

Metabolic Syndrome and Cardiov ...... Africa: The CASPIAN III Study

@en

type

label

Metabolic Syndrome and Cardiov ...... Africa: The CASPIAN III Study

@ast

Metabolic Syndrome and Cardiov ...... Africa: The CASPIAN III Study

@en

prefLabel

Metabolic Syndrome and Cardiov ...... Africa: The CASPIAN III Study

@ast

Metabolic Syndrome and Cardiov ...... Africa: The CASPIAN III Study

@en

P1433

Q36634531-18082CD9-3712-4144-8F98-C922C7A48525

P1476

Q36634531-A67A1245-41BF-4710-AAB8-84BCE0C2F47D

P2093

Q36634531-13AAF621-3EC2-4EC7-A33C-C3A3A11BAF09

Q36634531-184A6A97-74D3-43E6-82F0-36C1B02795D8

Q36634531-1A9F48B2-9887-4750-9F05-1E7675D9A617

Q36634531-1F3CBCBF-A77B-4C29-AD3E-5C8C238B2A55

Q36634531-6A218116-2897-40FE-B010-0E34FFFD5830

Q36634531-B8CCA2ED-385F-40A2-8870-F54B4FEF58EA

P2860

Q36634531-00B2CBB6-7EA0-4E74-BE38-1AD6960FB577

Q36634531-00CA8168-7F13-44DD-AC04-A6E188502FEE

Q36634531-09C03D3E-E942-4CCC-A859-EE155A6AE6E8

Q36634531-11E271BE-A5BE-4D6E-B60B-8C147238D4BA

Q36634531-18C01831-C2AB-4267-A137-BB40D1FC6395

Q36634531-1D573EEC-AEE3-47CA-9D3A-A9FC2C6B133A

Q36634531-1E40D530-C778-4499-BA54-84AB23B87E1F

Q36634531-20931C64-D031-4E30-9FE8-5C61815BA2D8

Q36634531-243B3E79-82D2-48F5-8AA6-B76B6595D70D

Q36634531-30CDEB73-89D2-4F42-B871-1BA071139A96

P304

Q36634531-709A8DBC-4CB5-4A55-9E42-5916562C3227

P31

Q36634531-367CC380-6393-4703-8537-1A30F847DB32

P356

Q36634531-221C32C7-08AC-4EBF-9556-8CF7F82FAAD4

P478

Q36634531-E33AC887-D84C-4A7D-9F2A-962D44620C6D

P50

Q36634531-47B92BCA-36F8-441A-8A7F-4B63A87C8B29

Q36634531-77307560-DB8B-4790-A763-33961DF3F401

Q36634531-D6A9B029-D3F9-44BB-BE86-8A83B7988EB7

Q36634531-E18BDA18-2CE6-472C-8B7C-21C4BD5D6115

P577

Q36634531-B92B5783-3040-476D-A979-FF5E8F0E686E

P5875

Q36634531-552CCF8A-BC4B-4BCE-B6C7-371590828F8E

P698

Q36634531-0758B75A-5792-4735-8CE7-3166AA00BADD

P921

Q36634531-00701CB9-4CED-461F-A752-A9C1AA8D26CE

Q36634531-25436887-6C01-45A6-ABD7-8AEA6DBE7442

Q36634531-4486BD76-7C8A-4F31-87A1-ED9A7A021AC5

Q36634531-9D233FD8-A716-4369-9E99-828245669A70

P932

Q36634531-7E157FF5-ADB9-412A-8DED-D81BF6AC8584

P356

P1433

International journal of endocrinology

P1476

Metabolic Syndrome and Cardiov ...... Africa: The CASPIAN III Study

@en

P2093

Gelayol Ardalan

http://www.w3.org/2001/XMLSchema#string

Mahnaz Taslimi

http://www.w3.org/2001/XMLSchema#string

Mohammad Esmaeil Motlagh

http://www.w3.org/2001/XMLSchema#string

Ramin Heshmat

http://www.w3.org/2001/XMLSchema#string

Tahere Aminaee

http://www.w3.org/2001/XMLSchema#string

Yasin Farrokhi-Khajeh-Pasha

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic syndrome: a multiplex cardiovascular risk factor

Banting lecture 1988. Role of insulin resistance in human disease

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

The metabolic syndrome--a new worldwide definition

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee

The metabolic syndrome in Chinese, Malays and Asian Indians. Factor analysis of data from the 1998 Singapore National Health Survey.

Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity.

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Waist Circumference, Body Mass Index, and Other Measures of Adiposity in Predicting Cardiovascular Disease Risk Factors among Peruvian Adults.

Methodology and Early Findings of the Third Survey of CASPIAN Study: A National School-based Surveillance of Students' High Risk Behaviors.

P304

702095

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/702095

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Patricia Khashayar

Mostafa Qorbani

Bagher Larijani

P577

2013-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235897113

http://www.w3.org/2001/XMLSchema#string

P698

23476647

http://www.w3.org/2001/XMLSchema#string

P921

Afelika ya Node

metabolic syndrome

P932

3580930

http://www.w3.org/2001/XMLSchema#string